Yoshio Hirano
Overview
Explore the profile of Yoshio Hirano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagano N, Hirano Y, Kimura M, Morita H, Yasukawa T
Stem Cell Res Ther
. 2024 Dec;
15(1):498.
PMID: 39716323
Background: Mesenchymal stem cells may have neuroprotective and tissue regenerative capabilities and the potential to rescue retinal degeneration in chorioretinal diseases including myopic chorioretinal atrophy. Transplantation of human (allogeneic) adipose...
2.
Makin R, Apicella I, Dholkawala R, Fukuda S, Hirahara S, Hirano Y, et al.
Angiogenesis
. 2024 Sep;
27(4):919-929.
PMID: 39316206
Inflammasome activation is implicated in diseases of aberrant angiogenesis such as age-related macular degeneration (AMD), though its precise role in choroidal neovascularization (CNV), a characteristic pathology of advanced AMD, is...
3.
Ando T, Kubota M, Yasukawa T, Miyase T, Ishiguro K, Esaki Y, et al.
Am J Ophthalmol Case Rep
. 2024 Aug;
36:102126.
PMID: 39149619
Purpose: To report a case of a full-thickness macular hole (FTMH) associated with a retinal pigment epithelium (RPE) tear after anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular...
4.
Electrical stimulation of the lower eyelid orbicularis oculi muscle improves periocular dark circles
Yasui Y, Kato H, Ogura S, Kimura M, Kato A, Hirano Y, et al.
Skin Res Technol
. 2024 Apr;
30(4):e13678.
PMID: 38616507
Background: We developed and tested the safety and efficacy of a cosmetic device to improve dark circles using electrical muscle stimulation of the orbicularis oculi muscle. Methods: Overall, 18 participants...
5.
Kurobe R, Hirano Y, Yuguchi T, Suzuki N, Yasukawa T
J Clin Med
. 2023 Nov;
12(21).
PMID: 37959176
Purpose: This study aims to investigate the factors influencing post-treatment visual acuity (VA) in patients with central retinal vein occlusion (CRVO) with macular edema (ME). Methods: The subjects of this...
6.
Ishiguro K, Hirano Y, Esaki Y, Yasukawa T
Case Rep Ophthalmol
. 2023 Jun;
14(1):234-240.
PMID: 37383170
A 47-year-old man presented with visual loss in the right eye 8 h after the first dose of a coronavirus disease 2019 (COVID-19) vaccine developed by Pfizer/BioNTech (BNT162b2). The best...
7.
Oshima Y, Shinojima A, Sawa M, Mori R, Sekiryu T, Kato A, et al.
PLoS One
. 2022 Feb;
17(2):e0264703.
PMID: 35213672
Purpose: To evaluate the progression of early age-related macular degeneration to neovascular age-related macular degeneration (nAMD), and identify the abnormal fundus autofluorescence (FAF) patterns and markers of choroidal neovascularization (CNV)...
8.
Kato A, Yasukawa T, Sugita I, Yoshida M, Nozaki M, Hirano Y, et al.
Adv Ther
. 2022 Feb;
39(3):1403-1416.
PMID: 35112307
Introduction: Anti-vascular endothelial growth factor (VEGF) therapy is the first-choice treatment for neovascular age-related macular degeneration (nvAMD); however, patients often are burdened physically, financially, and mentally. We investigated the relationship...
9.
Kurobe R, Hirano Y, Ogura S, Yasukawa T, Ogura Y
Clin Ophthalmol
. 2022 Jan;
15:4739-4745.
PMID: 34983997
Purpose: To investigate whether ultra-widefield (UWF) swept-source optical coherence tomography (SSOCT) system (Silverstone, Nikon Healthcare Japan, Inc, Tokyo, Japan) can obtain OCT images of peripheral retinal degenerations and breaks. Methods:...
10.
Kondo M, Noma H, Shimura M, Sugimoto M, Matsui Y, Kato K, et al.
J Clin Med
. 2021 Dec;
10(23).
PMID: 34884321
Purpose: To determine the baseline characteristics of patients with central retinal vein occlusion (CRVO) that were significantly associated with the best-corrected visual acuity (BCVA) at the initial examination. Methods: This...